SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-000539
Filing Date
2019-01-04
Accepted
2019-01-04 16:28:25
Documents
1
Period of Report
2019-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6055
  Complete submission text file 0000899243-19-000539.txt   7567
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Issuer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O AVROBIO, INC. ONE KENDALL SQUARE, BLDG. 300, #201 CAMBRIDGE MA 02139
Business Address
Ostrowski Erik (Reporting) CIK: 0001762507 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38537 | Film No.: 19510441